0
0
10/18/22 at 3:00pm
Organization
Medical Dialogues
Author
Dr. Shravani Dali
33 words
0
Comments
Researchers have found in a new study that risks for major adverse cardiac events and venous...
You are the first to view
https://medicaldialogues.in/cardiology-ctvs/news/adalimumab-use-in-ra-not-linked-to-increased-mace-and-vte-compared-to-jak-inhibitors-100776
Create an account
or login to join the discussion